New collaboration aims to bring population-scale whole-genome sequencing into everyday healthcare, enabling earlier risk detection and data-driven prevention SAN DIEGO ...

Foundation Medicine, Inc., a global precision medicine company, today announced the launch of its Whole Genome Sequencing (WGS) Germline test for research use. This important portfolio expansion is ...

A new study published in Science is challenging long-held assumptions about how we measure genetic risk in endangered species ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...

Genomics can help to identify people who are more likely to develop glaucoma potentially long before any symptoms of the disease appear. Instead ...

An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...

Waterborne pathogens, particularly Cryptosporidium, pose a growing public-health risk in Australia and globally. Cryptosporidiosis notifications have increased markedly in recent years across multiple ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.

Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:00 PM EDTCompany ParticipantsEmily Leproust ...

Meningitis: Health chiefs dealing with ‘explosive’ and ‘unprecedented’ outbreak - Some 15 cases of meningitis have so far been reported to the UK Health Security Agency, including two deaths.